Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 7412345...102030...Last »

GlaxoSmithKline’s new boss streamlines R&D

GSK’s new chief executive announced plans to narrow the focus of the group’s drug research by ditching 30-plus projects to improve returns in its core pharma business.

Read More »

Takeda, BioSurfaces Announce Research Program

Takeda and BioSurfaces announced a deal to initiate a research program designed to develop innovative medical devices to treat patients with GI diseases.

Read More »

Eli Lilly Shakes Up Cancer R&D Strategy

Eli Lilly reported an increase of 8 percent in second-quarter 2017 revenue, but the real shake-up is what the company plans to do with its pipeline.

Read More »

Lilly and Nektar Therapeutics Announce Alliance

Eli Lilly and Nektar Therapeutics announced a strategic collaboration to co-develop NKTR-358, a novel immunological therapy discovered by Nektar.

Read More »

Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for Parkinson’s Biotech NeuroDerm

Shares of Israel-based NeuroDerm Limited soared more than 16 percent in premarket trading after the company announced it was being snapped up by Tokyo-based Mitsubishi Tanabe Corporation.

Read More »

Corning, Merck & Co. and Pfizer to Invest $4 Billion and Create 4,000 New Jobs in the U.S.

Corning announced at President Trump’s “Made in America” event that the company planned to create 1,000 new high-tech jobs in the U.S.

Read More »

AstraZeneca CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo

July 21, 2017 By Alex Keown, BioSpace.com Breaking News Staff LONDON – After a period of uncertainty, AstraZeneca (AZN) Chief Executive Officer Pascal Soriot finally broke his silence to squelch rumors he was departing the company and urged his employees to remain focused on the company’s goals. In an internal memo sent earlier this week […]

Read More »

Endo International Slashes 875 Jobs and Will Shutter Alabama Facilities

July 21, 2017 By Alex Keown, BioSpace.com Breaking News Staff DUBLIN – Less than one month after Endo International (ENDP) agreed to pull its opioid pain medication, the reformulated Opana ER, from the market, the company announced it was shuttering a manufacturing facility in Alabama and terminating hundreds of employees. Endo said the move follows […]

Read More »

Ablynx signs Sanofi deal potentially worth up to $2.8 billion

French drugmaker Sanofi boosted its early-stage pipeline in immunology by signing a deal with Ablynx that could earn the Belgian biotech firm as much as 2.4 billion euros ($2.8 billion).

Read More »

Novartis Boss Updates Q2 2017 Financials, Reaffirms M&A Strategy

Novartis CEO Joe Jiminez spoke with investors and analysts regarding the company’s half-year financials.

Read More »

Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston

July 18, 2017 By Mark Terry, BioSpace.com Breaking News Staff Chicago, Ill. – Takeda Pharmaceuticals (TKPYY) is shifting hundreds of executives from the Chicago area to relocate to Boston. It is also cutting hundreds of field sales positions throughout the U.S.   In March, the company indicated it was making job cuts in the Cambridge, […]

Read More »

UDG Healthcare announces acquisition of Cambridge BioMarketing for up to $35M

UDG Healthcare plc announced the acquisition of Cambridge BioMarketing LLC, a U.S.-based healthcare communications business, for a total consideration of up to $35 million.

Read More »

Valeant Dumps Another Asset in Cash Deal

Valeant Pharmaceuticals is selling its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition Fund I for $190 million in cash.

Read More »

Anthem files lawsuit against Insys Therapeutics

Health insurer Anthem Inc. filed a lawsuit against Insys Therapeutics Inc., alleging the drugmaker fraudulently obtained reimbursements for its opioid painkiller Subsys.

Read More »

How to Lead in a “Do More with Less” Environment

From the leaders of marketing teams to medical affairs, pharma executives are increasingly required to do more with less. While this is true across industries, the U.S. biopharma industry is faced with unique headwinds.

Read More »

Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management

Novo Nordisk and Glooko announced that the new Cornerstones4Care Powered by Glooko app (C4C app) is now available to help people more effectively manage their diabetes.

Read More »

Settlement Reached in U.S. Cialis Patent Litigation

Eli Lilly entered into a settlement agreement with generic companies to resolve pending patent litigation regarding the Cialis (tadalafil) unit dose patent.

Read More »

GlaxoSmithKline Ends R&D Pact with OncoMed

OncoMed announced GlaxoSmithKline was terminating its nearly 10-year-old R&D agreement. OncoMed’s shares fell about 2 percent on the news.

Read More »

Nestle invests in microbiome diagnostics venture

Nestle is investing 20 million euros in a joint venture with Enterome SA to develop microbiome-based diagnostics for inflammatory bowel and liver diseases.

Read More »

Shire, Roche slug it out in hemophilia drug battle

Roche’s bid to take a chunk of the hemophilia drug market dominated by Shire took another blow with the Irish company winning a preliminary injunction.

Read More »

Page 1 of 7412345...102030...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2017 Focus: Payers, Biotech, HBA WOTY and more!

Subscribe

Ad Right Bottom

Main Navigation